UPDATED: Amarin takes application to expand Vascepa label to the FDA as M&A chatter heats up Endpoints News
Having unveiled an unexpected set of heart protective results for their fish oil-derived pill Vascepa, Amarin is marching ahead to fulfill blockbuster expectations ...
(CLICK HERE TO READ AND SEE MORE)
0 comments:
Post a Comment